apceth Biopharma GmbH, a cell therapy company with a proprietary portfolio of genetically modified mesenchymal stem cell therapeutics for the treatment of inflammatory diseases and cancer.
Quotient Clinical announced acquisition of QS Pharma, the contract development and manufacturing organisation from Charles River Laboratories International